RXRA and obesity disorder: Our study suggests that the activity of the PPAR-γ2–RXR-α heterodimer, either through the increased activation of co-activators, specific co-activator or specific PPAR-γ agonists, could have an interesting role in obesity and obesity related-insulin resistance.